erythrose has been researched along with temozolomide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agredano-Moreno, LT; Gallardo-Pérez, JC; Jimenez-García, LF; López-Marure, R; Robledo-Cadena, DX; Sánchez-Lozada, LG; Trejo-Solís, MC | 1 |
1 other study(ies) available for erythrose and temozolomide
| Article | Year |
|---|---|
Erythrose inhibits the progression to invasiveness and reverts drug resistance of cancer stem cells of glioblastoma.
Topics: Brain Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Glioblastoma; Humans; Neoplastic Stem Cells; Protein Serine-Threonine Kinases; Temozolomide; Tetroses | 2023 |